𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

✍ Scribed by Reddy, K. Rajender; Shiffman, Mitchell L.; Morgan, Timothy R.; Zeuzem, Stefan; Hadziyannis, Stephanos; Hamzeh, Fayez M.; Wright, Teresa L.; Fried, Michael

Book ID
123136389
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
131 KB
Volume
5
Category
Article
ISSN
1542-3565

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of weight-based ribavirin with pe
Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1
✍ Ira M. Jacobson; Robert S. Brown Jr; Jonathan McCone; Martin Black; Clive Albert πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 313 KB πŸ‘ 1 views

Brass, 14 for the WIN-R Study Group WIN-R (Weight-based dosing of pegINterferon alfa-2b and Ribavirin) was a multicenter, randomized, open-label, investigator-initiated trial involving 236 community and academic sites in the United States, comparing response to pegylated interferon (PEG-IFN) alfa-2b

Treatment of insulin resistance with met
Treatment of insulin resistance with metformin in naΓ―ve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
✍ Manuel Romero-GΓ³mez; MoisΓ©s Diago; RaΓΊl J. Andrade; JosΓ© L. Calleja; Javier Salm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12